Synergistic interactions between colistin and meropenem against extensively drug-resistant and pandrug-resistant Acinetobacter baumannii isolated from ICU patients

Int J Antimicrob Agents. 2015 Jun;45(6):670-1. doi: 10.1016/j.ijantimicag.2015.02.005. Epub 2015 Feb 26.

Authors

S Vourli¹, F Frantzeskaki², J Meletiadis³, L Stournara², A Armaganidis², L Zerva³, G Dimopoulos²

Affiliations

¹ Clinical Microbiology Laboratory, Attikon University Hospital, 1 Rimini Street, Haidari, 12462 Athens, Greece. Electronic address: [email protected].
² Critical Care Medicine, Attikon University Hospital, 1 Rimini Street, Haidari, 12462 Athens, Greece.
³ Clinical Microbiology Laboratory, Attikon University Hospital, 1 Rimini Street, Haidari, 12462 Athens, Greece.

PMID: 25795317
DOI: 10.1016/j.ijantimicag.2015.02.005

No abstract available

Publication types

Letter

MeSH terms

Acinetobacter Infections / microbiology*
Acinetobacter baumannii / drug effects*
Acinetobacter baumannii / isolation & purification
Anti-Bacterial Agents / pharmacology*
Colistin / pharmacology*
Drug Resistance, Multiple, Bacterial*
Drug Synergism*
Humans
Intensive Care Units
Meropenem
Microbial Sensitivity Tests
Thienamycins / pharmacology*

Substances

Anti-Bacterial Agents
Thienamycins
Meropenem
Colistin